BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage develop…
Biotechnology
US, Palo Alto [HQ]
BBIO/Financials
Wall Street · Earnings · Institutional Sentiment
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about BridgeBio Pharma, Inc.'s gradings, price targets and earnings estimates.
Earnings
See the historical earnings and what wall street
analysts forecasted and
forecast for
future earnings.
Reported
Past Estimate Consensus
Future Estimate Consensus
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2019 | - | -2.764 | - | 26 | - | -450 | - | -26 | - | -26 | - | 218 |
| 2020 | -2.4800 | -3.524 | 40 | 22 | -260 | -362 | -279 | -353 | -266 | -383 | 94 | 183 |
| 2021 | -4.1000 | -3.700 | 8 | 78 | -483 | -450 | -468 | -404 | -477 | -459 | 145 | 638 |
| 2022 | -4.4300 | -3.130 | 69 | 82 | -639 | -570 | -539 | -509 | -579 | -560 | 192 | 674 |
| 2023 | -3.3500 | -3.756 | 77 | 12 | -493 | -453 | -353 | -546 | -471 | -601 | 143 | 100 |
| 2024 | -3.9500 | -2.474 | 9 | 240 | -643 | -402 | -574 | -240 | -599 | -240 | 150 | 1,958 |
| 2025 | - | -3.123 | - | 209 | - | -585 | - | -209 | - | -209 | - | 1,704 |
| 2026 | - | -2.183 | - | 489 | - | 2.F7X | - | 2.F71 | - | 2.F711 | - | 2.F711 |
| 2027 | - | -0.395 | - | 1,022 | - | 1.F8X | - | 1.F81 | - | 1.F811 | - | 1.F811 |
| 2028 | - | 1.898 | - | 1,583 | - | 0.F9X | - | 0.F91 | - | 0.F911 | - | 0.F911 |
Institutional Sentiment
Wall Street · Earnings · Institutional Sentiment
Morgan Stanley
1Y Ago:
n/a
Prev. Grade
n/a
n/a
JP Morgan Chase
1Y Ago:
n/a
Prev. Grade
n/a
n/a
Citigroup
1Y Ago:
n/a
Prev. Grade
n/a
n/a
Overall Consensus
Grading Consensus
Price Target Consensus
-102.361% $24.28 · MISS
Nov. 6, 2024Price Then
$25.52
Price Target
$48.00
Price Now
$23.72